1. Metabolic surgery ameliorates cardiovascular risk in obese diabetic patients: Influence of different surgical procedures
- Author
-
Wei-Jei Lee, Jih Hua Wei, Ruey Hsing Chou, Shu Chun Chen, Po Hsun Huang, and Shing Jong Lin
- Subjects
medicine.medical_specialty ,Sleeve gastrectomy ,business.industry ,Gastric bypass surgery ,medicine.medical_treatment ,Type 2 Diabetes Mellitus ,030209 endocrinology & metabolism ,Type 2 diabetes ,medicine.disease ,medicine.disease_cause ,Surgery ,03 medical and health sciences ,0302 clinical medicine ,Diabetes mellitus ,Internal medicine ,Medicine ,030212 general & internal medicine ,Metabolic syndrome ,business ,Body mass index ,Glycemic - Abstract
Background In recent years, bariatric surgery was found to have therapeutic potential for the treatment of type 2 diabetes (T2D) in severely obese patients (body mass index [BMI] ≥35 kg/m2) and to reduce cardiovascular disease (CVD) risk and mortality. However, the benefit of CVD risk reduction after metabolic surgery in nonseverely obese T2D patients (BMI Objective To evaluate the CVD risk after metabolic surgery in T2D patients using The UK Prospective Diabetes Study score. Setting Tertiary referral general hospital, Taiwan, Republic of China. Methods Outcomes of 392 patients (235 women and 147 men) who had undergone sleeve gastrectomy (87) or gastric bypass (305) for treatment of T2D with 1-year follow-up were assessed. Data were prospectively collected for study, and cerebral and coronary heart disease risk was calculated by using The UK Prospective Diabetes Study risk engine. Outcomes of patients who had undergone different surgical procedures were assessed. Results One year after surgery, weight and glycemic control with complete and partial remission of T2D were significant in most of the patients. The 10-year coronary heart disease risk and fatal coronary heart disease risk were also reduced from 8.8% to 4.6% and from 4.6% to 2.1%, respectively (both P Conclusion The present study confirms the efficacy of metabolic surgery for the T2D treatment and reduction of CVD risk up to 50% 1 year after surgery. Gastric bypass surgery has more power on CVD risk reduction than sleeve gastrectomy.
- Published
- 2018